1. The angiotensin converting enzyme inhibitor captopril attenuates testosterone-induced benign prostatic hyperplasia in rats; a mechanistic approach
   Fatma Mostafa et al, 2019, European Journal of Pharmacology CrossRef
2. Cyclopamine functions as a suppressor of benign prostatic hyperplasia by inhibiting epithelial and stromal cell proliferation via suppression of the Hedgehog signaling pathway
   Yi‑Feng Yuan et al, 2020, International Journal of Molecular Medicine CrossRef
3. Global hotspots and future directions for drugs to improve the skin flap survival: A bibliometric and visualized review
   Shuangmeng Jia et al, 2024, Journal of Pharmaceutical Analysis CrossRef
4. Kolaviron modulates angiogenesis, apoptosis and inflammatory signaling in rat model of testosterone propionate-induced benign prostate hyperplasia
   Ebenezer O. Farombi et al, 2023, Inflammopharmacology CrossRef
5. The Effect of Xialiqi Capsule on Testosterone-Induced Benign Prostatic Hyperplasia in Rats
   Hongcai Cai et al, 2018, Evidence-Based Complementary and Alternative Medicine CrossRef
6. Pseudoginsenoside F11 Enhances the Viability of Random-Pattern Skin Flaps by Promoting TFEB Nuclear Translocation Through AMPK-mTOR Signal Pathway
   Feiya Zhou et al, 2021, Frontiers in Pharmacology CrossRef
7. Qianliening Capsule Promotes Mitochondrial Pathway Mediated the Apoptosis of Benign Prostatic Hyperplasia Epithelial-1 Cells by Regulating the miRNA-181a
   Jianheng Zhou et al, 2018, International Journal of Gerontology CrossRef
8. Influence ofPanax ginsengon Alpha-Adrenergic Receptor of Benign Prostatic Hyperplasia
   Su Kang Kim et al, 2014, International Neurourology Journal CrossRef